AMAT vs IBIO · P/E 56, rev $24.04B vs rev $100.0K
Applied Materials Inc (AMAT) versus iBio, Inc. Common Stock (IBIO) — a side-by-side from cached financials, not a winner call.
Applied Materials Inc (AMAT) is a semiconductor equipment & materials company listed on NASDAQ.
iBio, Inc. Common Stock (IBIO) is a biotechnology company listed on US.
Latest reported AMAT revenue for 2026-07-26 was $24.04B. Net income was $7.37B. AMAT currently screens at market cap $470.75B and trailing P/E 55.8.
Latest reported IBIO revenue for 2026-06-30 was $100.0K. Net income was -$32.8M. Revenue was down 75.0% from 2025-06-30 to 2026-06-30. IBIO currently screens at market cap $13.4M.
AMAT currently screens at market cap $470.75B and trailing P/E 55.8. IBIO currently screens at market cap $13.4M.
Not investment advice. Open the AMAT and IBIO stock pages for the full models.
Not investment advice.